Racial/ethnic disparities in human DNA methylation

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1846, Issue 1, 2014, Pages 258-262

  Xia, Yin yin ^a   Ding, Yu bing ^a   Liu, Xue qing ^a   Chen, Xue mei ^a   Cheng, Shu qun ^a   Li, Lian bing ^b   Ma, Ming fu ^b   He, Jun lin ^a   Wang, Ying xiong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Population and Family Planning Science and Technology Research Institute   (China)

Author keywords

Cancer; DNA methylation; Individual susceptibility; Racial ethnic disparities

Indexed keywords

DNA;

BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLORECTAL CANCER; CPG ISLAND; DISEASE ACTIVITY; DNA METHYLATION; DNA METHYLATION ASSAY; ETHNIC DIFFERENCE; ETHNICITY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; LUNG CANCER; MALIGNANT MESOTHELIOMA; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; REVIEW;

CANCER; DNA METHYLATION; INDIVIDUAL SUSCEPTIBILITY; RACIAL/ETHNIC DISPARITIES;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CONTINENTAL POPULATION GROUPS; DNA METHYLATION; ETHNIC GROUPS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 84905240847     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2014.07.001     Document Type: Review

References (43)

1. Antequera F., Bird A. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:11995-11999.
2. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
3. Adkins R.M., Krushkal J., Tylavsky F.A., Thomas F. Racial differences in gene-specific DNA methylation levels are present at birth, birth defects research. Clin. Mol. Teratol. A 2011, 91:728-736.
4. Quon G., Lippert C., Heckerman D., Listgarten J. Patterns of methylation heritability in a genome-wide analysis of four brain regions. Nucleic Acids Res. 2013, 41:2095-2104.
5. Ogino S., Lochhead P., Chan A.T., Nishihara R., Cho E., Wolpin B.M., Meyerhardt J.A., Meissner A., Schernhammer E.S., Fuchs C.S., Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod. Pathol. 2013, 26:465-484.
6. Kim K.C., Friso S., Choi S.W. DNA methylation, an epigenetic mechanism connecting folate to healthy embryonic development and aging. J. Nutr. Biochem. 2009, 20:917-926.
7. Smith G.D. Epidemiology, epigenetics and the 'Gloomy Prospect': embracing randomness in population health research and practice. Int. J. Epidemiol. 2011, 40:537-562.
8. Fraser H.B., Lam L.L., Neumann S.M., Kobor M.S. Population-specificity of human DNA methylation. Genome Biol. 2012, 13:R8.
9. Terry M.B., Ferris J.S., Pilsner R., Flom J.D., Tehranifar P., Santella R.M., Gamble M.V., Susser E. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol. Biomarkers Prev. 2008, 17:2306-2310.
10. Hsiung D.T., Marsit C.J., Houseman E.A., Eddy K., Furniss C.S., McClean M.D., Kelsey K.T. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2007, 16:108-114.
11. Zhang F.F., Cardarelli R., Carroll J., Fulda K.G., Kaur M., Gonzalez K., Vishwanatha J.K., Santella R.M., Morabia A. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics 2011, 6:623-629.
12. Kitkumthorn N., Mutirangura A. Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications. Clin. Epigenetics 2011, 2:315-330.
13. Dumitrescu R.G., Marian C., Krishnan S.S., Spear S.L., Kallakury B.V., Perry D.J., Convit J.R., Seillier-Moiseiwitsch F., Yang Y., Freudenheim J.L., Shields P.G. Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women. J. Cell. Mol. Med. 2010, 14:1468-1475.
14. Wallace K., Grau M.V., Levine A.J., Shen L., Hamdan R., Chen X., Gui J., Haile R.W., Barry E.L., Ahnen D., McKeown-Eyssen G., Baron J.A., Issa J.P. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev. Res. (Phila) 2010, 3:1552-1564.
15. Kwabi-Addo B., Wang S., Chung W., Jelinek J., Patierno S.R., Wang B.D., Andrawis R., Lee N.H., Apprey V., Issa J.P., Ittmann M. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin. Cancer Res. 2010, 16:3539-3547.
16. Nielsen D.A., Hamon S., Yuferov V., Jackson C., Ho A., Ott J., Kreek M.J. Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Hum. Genet. 2010, 127:639-649.
17. Andraos C., Koorsen G., Knight J.C., Bornman L. Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis, and TaqI polymorphism. Hum. Immunol. 2011, 72:262-268.
18. Enokida H., Shiina H., Urakami S., Igawa M., Ogishima T., Pookot D., Li L.C., Tabatabai Z.L., Kawahara M., Nakagawa M., Kane C.J., Carroll P.R., Dahiya R. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int. J. Cancer 2005, 116:174-181.
19. Woodson K., Hanson J., Tangrea J. A survey of gene-specific methylation in human prostate cancer among black and white men. Cancer Lett. 2004, 205:181-188.
20. Woodson K., Hayes R., Wideroff L., Villaruz L., Tangrea J. Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate 2003, 55:199-205.
21. Li L.C. Epigenetics of prostate cancer. Front. Biosci. 2007, 12:3377-3397.
22. Das P.M., Ramachandran K., Vanwert J., Ferdinand L., Gopisetty G., Reis I.M., Singal R. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Mol. Cancer 2006, 5:28.
23. Tang D., Kryvenko O.N., Mitrache N., Do K.C., Jankowski M., Chitale D.A., Trudeau S., Rundle A., Belinsky S.A., Rybicki B.A. Methylation of the RARB gene increases prostate cancer risk in black Americans. J. Urol. 2013, 190:317-324.
24. Couzin J. Cancer research. Probing the roots of race and cancer. Science 2007, 315:592-594.
25. Christensen B.C., Kelsey K.T., Zheng S., Houseman E.A., Marsit C.J., Wrensch M.R., Wiemels J.L., Nelson H.H., Karagas M.R., Kushi L.H., Kwan M.L., Wiencke J.K. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet. 2010, 6:e1001043.
26. Mehrotra J., Ganpat M.M., Kanaan Y., Fackler M.J., McVeigh M., Lahti-Domenici J., Polyak K., Argani P., Naab T., Garrett E., Parmigiani G., Broome C., Sukumar S. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin. Cancer Res. 2004, 10:2052-2057.
27. Wang S., Dorsey T.H., Terunuma A., Kittles R.A., Ambs S., Kwabi-Addo B. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS ONE 2012, 7:e37928.
28. Barchana M., Liphshitz I., Rozen P. Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations. Familial Cancer 2004, 3:207-214.
29. Mokarram P., Kumar K., Brim H., Naghibalhossaini F., Saberi-firoozi M., Nouraie M., Green R., Lee E., Smoot D.T., Ashktorab H. Distinct high-profile methylated genes in colorectal cancer. PLoS ONE 2009, 4:e7012.
30. Vilkin A., Niv Y., Nagasaka T., Morgenstern S., Levi Z., Fireman Z., Fuerst F., Goel A., Boland C.R. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel. Cancer 2009, 115:760-769.
31. Ghafoor A., Jemal A., Cokkinides V., Cardinez C., Murray T., Samuels A., Thun M.J. Cancer statistics for African Americans. CA Cancer J. Clin. 2002, 52:326-341.
32. Figueiredo J.C., Grau M.V., Wallace K., Levine A.J., Shen L., Hamdan R., Chen X., Bresalier R.S., McKeown-Eyssen G., Haile R.W., Baron J.A., Issa J.P. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol. Biomarkers Prev. 2009, 18:1041-1049.
33. Piyathilake C.J., Henao O., Frost A.R., Macaluso M., Bell W.C., Johanning G.L., Heimburger D.C., Niveleau A., Grizzle W.E. Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States). Cancer Causes Control 2003, 14:37-42.
34. Toyooka S., Maruyama R., Toyooka K.O., McLerran D., Feng Z., Fukuyama Y., Virmani A.K., Zochbauer-Muller S., Tsukuda K., Sugio K., Shimizu N., Shimizu K., Lee H., Chen C.Y., Fong K.M., Gilcrease M., Roth J.A., Minna J.D., Gazdar A.F. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int. J. Cancer 2003, 103:153-160.
35. Kimura K., Toyooka S., Tsukuda K., Yamamoto H., Suehisa H., Soh J., Otani H., Kubo T., Aoe K., Fujimoto N., Kishimoto T., Sano Y., Pass H.I., Date H. The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas. Oncol. Rep. 2008, 20:1265-1268.
36. Tomii K., Tsukuda K., Toyooka S., Dote H., Hanafusa T., Asano H., Naitou M., Doihara H., Kisimoto T., Katayama H., Pass H.I., Date H., Shimizu N. Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. Int. J. Cancer 2007, 120:566-573.
37. Henderson T.O., Bhatia S., Pinto N., London W.B., McGrady P., Crotty C., Sun C.L., Cohn S.L. Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study. J. Clin. Oncol. 2011, 29:76-82.
38. Asada K., Watanabe N., Nakamura Y., Ohira M., Westermann F., Schwab M., Nakagawara A., Ushijima T. Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomas. Jpn. J. Clin. Oncol. 2013, 43:641-645.
39. Powell M.A., Mutch D.G., Rader J.S., Herzog T.J., Huang T.H., Goodfellow P.J. Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker. Cancer 2002, 94:2941-2952.
40. Verhoeven K.J., Jansen J.J., van Dijk P.J., Biere A. Stress-induced DNA methylation changes and their heritability in asexual dandelions. New Phytol. 2010, 185:1108-1118.
41. Mensaert K., Denil S., Trooskens G., Van Criekinge W., Thas O., De Meyer T. Next-generation technologies and data analytical approaches for epigenomics. Environ. Mol. Mutagen. 2014, 55:155-170.
42. von Kanel T., Huber A.R. DNA methylation analysis. Swiss Med. Wkly. 2013, 143:w13799.
43. Ioannidis J.P.A. Why most published research findings are false. PLos Med. 2005, 2:696-701.